Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.
Miyamoto M, Takano M, Kuwahara M, Soyama H, Kato K, Matuura H, Sakamoto T, Takasaki K, Aoyama T, Yoshikawa T, Furuya K. Miyamoto M, et al. Among authors: sakamoto t. Cancer Chemother Pharmacol. 2018 Jan;81(1):111-117. doi: 10.1007/s00280-017-3454-y. Epub 2017 Nov 9. Cancer Chemother Pharmacol. 2018. PMID: 29124328 Review.
Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine.
Soyama H, Miyamoto M, Matsuura H, Iwahashi H, Kakimoto S, Ishibashi H, Sakamoto T, Hada T, Suminokura J, Takano M. Soyama H, et al. Among authors: sakamoto t. Cancer Chemother Pharmacol. 2020 May;85(5):941-947. doi: 10.1007/s00280-020-04070-8. Epub 2020 Apr 11. Cancer Chemother Pharmacol. 2020. PMID: 32279102
Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin.
Soyama H, Miyamoto M, Takano M, Aoyama T, Matsuura H, Sakamoto T, Takasaki K, Kuwahara M, Kato K, Yoshikawa T, Iwahashi H, Tsuda H, Furuya K. Soyama H, et al. Among authors: sakamoto t. Med Oncol. 2017 Nov 22;34(12):201. doi: 10.1007/s12032-017-1058-3. Med Oncol. 2017. PMID: 29168038
Analysis of prophylactic Bakri balloon tamponade failure in patients with placenta previa.
Soyama H, Miyamoto M, Ishibashi H, Nakatsuka M, Kawauchi H, Sakamoto T, Matuura H, Kuwahara M, Takasaki K, Iwahashi H, Kato K, Yoshida M, Takano M, Sasa H, Furuya K. Soyama H, et al. Among authors: sakamoto t. Taiwan J Obstet Gynecol. 2019 Jan;58(1):159-163. doi: 10.1016/j.tjog.2018.11.029. Taiwan J Obstet Gynecol. 2019. PMID: 30638472 Free article.
5,263 results